Dermapharm Holding SE buy thorstenm
Start price
12.01.23
/
80%
€39.44
Target price
12.01.26
€60.00
Performance (%)
-2.76%
End price
12.01.26
€38.35
Summary
This prediction ended on 12.01.26 with a price of €38.35. With a performance of -2.76%, the BUY prediction for Dermapharm Holding SE by thorstenm closed slightly in the red. thorstenm has 80% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -3.957% | -3.957% | 22.845% | 7.829% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by thorstenm for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Die von thorstenm gewählte maximale Laufzeit wurde überschritten